OE19

OE19

Cat.No.: CSC-C9230W

Species: Homo sapiens (Human)

Source: Esophagus

Morphology: epithelial

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9230W
Description
Established from the primary tumor of a 72-year-old Caucasian man with esophageal adenocarcinoma in 1993; cell line also known as JROECL19
Species
Homo sapiens (Human)
Source
Esophagus
Recommended Medium
80-90% RPMI-1640 + 10-20% h.i. FBS
Morphology
epithelial
Disease
Esophageal Adenocarcinoma
Storage and Shipping
frozen with 70% medium, 20% FBS, 10% DMSO
Synonyms
OE-19; JROECL 19; JROECL19; OEC19
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

OE19 is a rigorously authenticated human esophageal adenocarcinoma (EAC) cell line established in 1993 from a Stage III, moderately differentiated adenocarcinoma of the gastric cardia/esophagogastric junction. As one of only nine verified EAC lines authenticated by genotype-matched primary tissue analysis, OE19 offers exceptional model fidelity.

Molecularly, OE19 is defined by ~100-fold ERBB2 (HER2) amplification with robust protein overexpression, making it a premier preclinical model for HER2-targeted therapy evaluation. Critically, the line harbors wild-type KRAS and BRAF alongside microsatellite-stable (MSS) status, providing a clean genetic background devoid of confounding RAS/RAF-mediated resistance pathways. TP53 mutation (N310K frameshift) and preserved expression of epithelial differentiation markers (CK8/18, EpCAM, E-cadherin, MUC1) further validate its EAC identity.

Functionally, OE19 demonstrates potent tumorigenicity in immunodeficient mice, forming palpable subcutaneous xenografts within 7–10 days and reliably producing bloody ascites with liver metastasis in intraperitoneal dissemination models. Its documented sensitivity to paclitaxel and established utility in 3D culture and high-throughput drug screening platforms underscore its translational relevance. With comprehensive STR profiling and decades of peer-reviewed validation, OE19 remains the gold-standard EAC model for mechanistic studies and therapeutic development in gastroesophageal malignancies.

AGR2 Depletion and ER Stress Remodel the OE19 Secretome

The endoplasmic reticulum (ER) chaperone Anterior Gradient 2 (AGR2) is overexpressed in various adenocarcinomas, promoting tumor progression and chemoresistance. However, its exact role in modulating the Unfolded Protein Response (UPR) and remodeling the cancer cell secretome under proteotoxic stress remains poorly understood. Using shRNA-mediated silencing of AGR2 combined with high-throughput LC-MS/MS proteomic analysis in OE19 gastroesophageal junction adenocarcinoma cells, Bourgery, Quentin, et al. profiled the global changes in protein secretion under basal and tunicamycin-induced ER stress conditions.

AGR2 silencing efficiency was confirmed by Western blotting (Fig. 1A), and reduced AGR2 levels also impaired clonogenic growth (Fig. 1B). Secretome profiling by LC-MS/MS of exosome-free conditioned media across four conditions (shCtrl, shAGR2, shCtrl + Tun, shAGR2 + Tun) revealed extensive remodeling of secreted protein profiles. Volcano plot analysis identified 93 differentially secreted proteins under basal conditions and between 93 and 97 under ER stress (Fig. 1C). In both conditions, AGR2 depletion was associated with a predominant increase in protein secretion relative to controls. Principal Component Analysis (PCA) showed clear segregation of the four experimental groups, indicating distinct secretory signatures associated with AGR2 status and ER stress (Fig. 1D). Heatmap analysis further illustrated the differential secretion patterns across conditions and the clustering of secreted proteins (Fig. 1E). Comparative analysis identified a core set of 75 common differentially secreted proteins across conditions. Functional enrichment analysis revealed significant enrichment of pathways involved in hemostasis and extracellular matrix organization, linking AGR2-dependent secretome changes to microenvironmental remodeling (Fig. 1F).

Impact of AGR2 on cellular phenotype and secretome regulation in OE19 cells.
Fig. 1. Impact of AGR2 on cellular phenotype and secretome regulation in OE19 cells (Bourgery, Quentin, et al., 2026).

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products